Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm Open-Label Trial Evaluating the Efficacy of Suzetrigine (Journavx) in Multimodal Postoperative Pain Management Following Thumb Basal Joint Arthroplasty

NCT07723352 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.

NCT NCT07723352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07723352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm Open-Label Trial Evaluating the Efficacy of Suzetrigine (Journavx) in Multimodal Postoperative Pain Management Following Thumb Basal Joint Arthroplasty
Lead sponsor
Rothman Institute Orthopaedics
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 21, 2026
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

joint replacement, joint replacement surgery, postoperative pain, thumb basal joint osteoarthritis